SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-189475
Filing Date
2022-07-07
Accepted
2022-07-07 16:18:39
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d295618ddefa14a.htm DEFA14A 28279
2 GRAPHIC g295618txs10g1.jpg GRAPHIC 520925
3 GRAPHIC g295618txs11g1.jpg GRAPHIC 1043013
4 GRAPHIC g295618txs1g1.jpg GRAPHIC 1126460
5 GRAPHIC g295618txs2g1.jpg GRAPHIC 2277599
6 GRAPHIC g295618txs3g1.jpg GRAPHIC 1037171
7 GRAPHIC g295618txs4g1.jpg GRAPHIC 854943
8 GRAPHIC g295618txs5g1.jpg GRAPHIC 858656
9 GRAPHIC g295618txs6g1.jpg GRAPHIC 797074
10 GRAPHIC g295618txs7g1.jpg GRAPHIC 1190651
11 GRAPHIC g295618txs8g1.jpg GRAPHIC 1125847
12 GRAPHIC g295618txs9g1.jpg GRAPHIC 914593
  Complete submission text file 0001193125-22-189475.txt   16208201
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33500 | Film No.: 221071846
SIC: 2834 Pharmaceutical Preparations